COMMENT The work by Schindler and colleagues at the Knight ADRC adds to the growing number of studies showing CSF biomarker levels to differ between racial groups. Such studies—including our own—have been criticized in the past for highlighting how a social ...
PAPER Schindler SE, Cruchaga C, Joseph A, McCue L, Farias FH, Wilkins CH, Deming Y, Henson RL, Mikesell RJ, Piccio L, Llibre-Guerra JJ, Moulder KL, Fagan AM, Ances BM, Benzinger TL, Xiong C, Holtzman DM, Morris JC33884297
PAPER Wu J, Kraja AT, Oberman A, Lewis CE, Ellison RC, Arnett DK, Heiss G, Lalouel JM, Turner ST, Hunt SC, Province MA, Rao DC16053990
PAPER Chekka LM, Chapman AB, Gums JG, Cooper-DeHoff RM, Johnson JA
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone.Am J Med. 2021 Jan 9; PubMed: 33434556
PAPER Clemmer JS, Pruett WA, Lirette ST33392272
CONFERENCE COVERAGE 2021-04-07 Conference Coverage Part 2 of a two-part story. Click here for Part 1. The COVID-19 pandemic has touched every aspect of health, from neurologic disease broadly (see Part 1 of this story) to clinical research. At the 15th International Conference on ...
CONFERENCE COVERAGE 2021-04-07 Conference Coverage Part 1 of a two-part story. Click here for Part 2. As COVID-19 drove yet another conference online, it was also the topic of discussions there—held from the dull safety of researchers' home screens. At the 15th International ...
PAPER Boldrini M, Canoll PD, Klein RS33769431
PAPER Lou JJ, Movassaghi M, Gordy D, Olson MG, Zhang T, Khurana MS, Chen Z, Perez-Rosendahl M, Thammachantha S, Singer EJ, Magaki SD, Vinters HV, Yong WH33554218
Baycrest HospitalNorth York, Canada
PAPER Ahmad FB, Anderson RN33787821
NationalCentre Epidemiology. Carlos III Inst HealthMadrid, Spain
PAPER Franklin GL, Ferreira CH, Teive HA33816689
PAPER Naia L, Ly P, Mota SI, Lopes C, Maranga C, Coelho P, Gershoni-Emek N, Ankarcrona M, Geva M, Hayden MR, Rego AC
The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models.Neurotherapeutics. 2021 Apr 1; PubMed: 33797036
PAPER Nair A, Johnson EB, Gregory S, Osborne-Crowley K, Zeun P, Scahill RI, Lowe J, Papoutsi M, Palminteri S, Rutledge RB, Rees G, Tabrizi SJ33795209